Pancreatic Cancer Research

ResearcherFriedrich-Alexander-Universität Erlangen-NürnbergActive in the last 2 years

Paul David

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-9643-3657; OpenAlex author ID A5050370381. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
18
Papers, trials and grants by year

2023: 1 paper · 2024: 2 papers · 2025: 3 papers · 2026: 2 papers

Papers 8

  1. Immune Cell-Specific and Isoform-Selective Regulation of CD44 in Pancreatic Ductal Adenocarcinoma Links Lymph Node Variant Loss and Exosomal CD44 to Clinical O… Last author DOI 10.3390/cells15050411↗
  2. Post-Surgical Remodeling of Circulating Monocytes Identifies CD86 Expression on Non-Classical Monocytes as a Prognostic Indicator in Pancreatic Ductal Adenocar… Last author DOI 10.3390/ijms27115012↗
  3. Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarc… Co-author DOI 10.3390/ijms26041500↗
  4. Increased Herpesvirus Entry Mediator Expression on Circulating Monocytes and Subsets Predicts Poor Outcomes in Pancreatic Ductal Adenocarcinoma Patients. Last author DOI 10.3390/ijms26072875↗
  5. Identification of Cancer Associated Fibroblasts Related Genes Signature to Facilitate Improved Prediction of Prognosis and Responses to Therapy in Patients wit… Last author DOI 10.3390/ijms26104876↗
  6. CD71 expressing circulating neutrophils serve as a novel prognostic biomarker for metastatic spread and reduced outcome in pancreatic ductal adenocarcinoma pat… Last author DOI 10.1038/s41598-024-70916-3↗
  7. Exosomal ROR1 in peritoneal fluid identifies peritoneal disseminated PDAC and is associated with poor survival. Co-author DOI 10.3389/fimmu.2024.1253072↗
  8. Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients. First author DOI 10.3390/cancers15020363↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Georg F. Weber · 8 shared papers, 2023–2026 · strength 1.55
  2. Robert Grützmann · 7 shared papers, 2023–2026 · strength 1.34
  3. Anke Mittelstädt · 7 shared papers, 2023–2026 · strength 1.31
  4. Christian Krautz · 6 shared papers, 2023–2026 · strength 1.10
  5. Maximilian Brunner · 6 shared papers, 2023–2026 · strength 1.10
  6. Frederik J. Hansen · 6 shared papers, 2023–2026 · strength 1.08
  7. Isabelle Kuchenreuther · 4 shared papers, 2024–2026 · strength 0.80
  8. Alara Karabiber · 4 shared papers, 2024–2026 · strength 0.79
  9. Lisa-Sophie Arnold · 3 shared papers, 2024–2026 · strength 0.58
  10. Anne Jacobsen · 3 shared papers, 2024–2026 · strength 0.53
  11. Yong Jian Zhou · 2 shared papers, 2025–2026 · strength 0.46
  12. Yanxi Lu · 1 shared paper, 2025 · strength 0.24
  13. Christian P. Pilarsky · 1 shared paper, 2025 · strength 0.24
  14. Timur Buniatov · 1 shared paper, 2024 · strength 0.15
  15. Sabine Semrau · 1 shared paper, 2024 · strength 0.15
  16. Yurdagül Zopf · 1 shared paper, 2024 · strength 0.15
  17. Axel Denz · 1 shared paper, 2024 · strength 0.15
  18. Danilo Hackner · 1 shared paper, 2024 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.